MedPath

To study add on effect of Gomutra Triphala Vati with oral Hypoglycemic agent in Prameha(Type II Diabetes Mellitus)

Not Applicable
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2023/10/058920
Lead Sponsor
PDEAs College Of Ayurved And Research Centre Nigdi pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age group between 35 to 60 years.

2. Known case of Type-2 DM, Non insulin dependent diabetes mellitus.

3. Patient having HbA1C between 6.5 – 10.

4. Patient with fasting blood sugar up to 250 mg/dl and post prandial blood sugar

up to 350 mg/dl

5. Patient taking Oral hypoglycemic drug since minimum 6 months.

Exclusion Criteria

1. Juvenile Diabetes and Insulin Dependent Diabetes Mellitus (IDDM).

2. Post covid diabetic patients.

3. Patients with Renal Disorders like Chronic kidney disease and Acute kidney

diseases.

4. Patients with acute complications Hyperglycemic & hypoglycemic coma,

Ketoacidosis and related complication and Infections like gangrene.

5. Patients with chronic diabetic complications Nephropathy, Neuropathy and

Retinopathy.

6. Pregnant & lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the add on effect of Gomutra Triphala Vati 500mg twice a day with oral hypoglycemic agent <br/ ><br>in Prameha (Type II DM) for 3 months.Timepoint: study time 3 months <br/ ><br>follow up 30th, 60th, 90th days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To observe adverse effects if any.Timepoint: study time 3 months <br/ ><br>follow up 30th, 60th, 90th days
© Copyright 2025. All Rights Reserved by MedPath